Quick Answer
Amneal Pharmaceuticals, Inc. reported Gross Profit of $1.11 billion for fiscal year 2025.
Amneal Pharmaceuticals, Inc. Gross Profit — Annual History
| Fiscal Year | Gross Profit | YoY Change |
|---|---|---|
| 2025 | $1.11B | +9.1% |
| 2024 | $1.02B | +24.4% |
| 2023 | $820.57M | +4.6% |
| 2022 | $784.71M | +2.0% |
| 2021 | $768.97M | +22.4% |
| 2020 | $628.39M | +78.0% |
| 2019 | $353.00M | -50.7% |
| 2018 | $716.40M | +36.2% |
| 2017 | $526.18M | -11.9% |
| 2016 | $597.46M | — |
Quarterly Gross Profit
| Quarter Ending | Gross Profit | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $273.97M | +1.6% | -4.3% |
| June 30, 2025 | $286.25M | +14.5% | +11.9% |
| March 31, 2025 | $255.89M | +7.5% | -5.1% |
| September 30, 2024 | $269.56M | +15.9% | +7.8% |
| June 30, 2024 | $249.95M | +13.6% | +5.0% |
| March 31, 2024 | $238.06M | +33.6% | +2.4% |
| September 30, 2023 | $232.53M | +19.7% | +5.7% |
| June 30, 2023 | $220.02M | +9.7% | +23.5% |
- Amneal Pharmaceuticals, Inc. showed an increase of +9.1% in Gross Profit compared to the prior fiscal year.
- Over the 2016–2025 period, Amneal Pharmaceuticals, Inc.’s gross profit has grown by 86.3% (from $597.46 million to $1.11 billion).
- The most recent figure is from Amneal Pharmaceuticals, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 27, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: